AI Buyer Insights:

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Jiangsu Hengrui Medicine Data, Technology Stack, and Enterprise Applications
Collaboration
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2021 2021
Collaboration Collaboration 2022 2022
ITSM
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
TeamViewer Legacy TeamViewer Remote Monitoring and Management ITSM n/a 2022 2022
IT Decision Makers and Key Stakeholders at Jiangsu Hengrui Medicine
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Jiangsu Hengrui Medicine Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Jiangsu Hengrui Medicine Technographics

Jiangsu Hengrui Medicine is a Life Sciences organization based in China, with around 24491 employees and annual revenues of $3.76 billion.

Jiangsu Hengrui Medicine operates a diverse technology stack with applications such as Microsoft 365 and TeamViewer, covering areas like Collaboration and Remote Monitoring and Management.

Jiangsu Hengrui Medicine has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft and TeamViewer.

Jiangsu Hengrui Medicine recently adopted applications including Slack Connect in 2022, TeamViewer in 2022 and Microsoft 365 in 2021, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Jiangsu Hengrui Medicine’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Jiangsu Hengrui Medicine’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Jiangsu Hengrui Medicine technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.